Product
Supplier
Encyclopedia
Inquiry
Iguratimod Api buy - large image1
Iguratimod Api buy - image1

Iguratimod Api

12 Inquiries

Unit Price: Get Latest Price
CAS No.:

123663-49-0

Grade:

Pharmaceutical Grade

Content:

99%

Packaging:

15kg/Cardboard Drum

Price valid (until):

2023-05-25

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    Basic Info
    Product Name:

    Iguratimod

    Other Name:

    Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide;T 614;3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one;Iguratimod;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-chromen-7-yl]methanesulfonamide;T 614 (antiinflammatory);Careram;Kolbet

    CAS No.:

    123663-49-0

    Molecular Formula:

    C17H14N2O6S

    InChIKeys:

    InChIKey=ANMATWQYLIFGOK-UHFFFAOYSA-N

    Molecular Weight:

    374.37

    Exact Mass:

    374.37

    EC Number:

    1308068-626-2

    UNII:

    4IHY34Y2NV

    DSSTox ID:

    DTXSID0048971

    HScode:

    2935009090

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    119

    XLogP3:

    1.4

    Density:

    1.52±0.1 g/cm3(Predicted)

    Melting Point:

    238.0 to 242.0 °C

    Boiling Point:

    580.6±60.0 °C(Predicted)

    Flash Point:

    304.9±32.9 °C

    Refractive Index:

    1.674

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod

    Location:

    Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    20

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    201-300

    Year of Establishment:

    2021

    Alicorn Pharmaceutical is a leading Manufactory supplier of Iguratimod, AR-13324 (mesylate), Safinamide based in Jiaxing, Zhejiang, China. With a commitment to quality and customer satisfaction, Alicorn Pharmaceutical has become a trusted name in the industry. Our product line includes a range of high-quality Iguratimod, AR-13324 (mesylate), Safinamide, which are available at competitive prices. Alicorn Pharmaceutical has established itself as a reliable supplier of chemical products on the echemi.com.

  • Inquiry History
    12 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Iguratimod

    1.00 KG Jan 19, 2024
    India

    Iguratimod

    4 KG Jul 21, 2025
    India

    Iguratimod

    100.00 KG Aug 28, 2024
    India

    Iguratimod

    100.00 KG Aug 5, 2024
    India

    Iguratimod

    100.00 KG Aug 2, 2024
    India

    Iguratimod

    500 KG May 16, 2024
    India

    Febuxostat

    1.00 KG Jan 19, 2024
    India

    Linagliptin

    1.00 KG Jan 19, 2024
    India

    URSODEOXYCHOLIC ACID

    10.00 KG Mar 6, 2024
    India

    Acarbose

    10.00 KG Mar 6, 2024
    India

    Upadacitinib

    10.00 KG Mar 6, 2024
    India

    Ripretinib

    10.00 KG Mar 6, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.